The Effectiveness of Low Dead Space Syringes for Reducing the Risk of Hepatitis C Virus Acquisition among People Who Inject Drugs: Findings from a National Survey in England, Wales, and Northern Ireland

Adam Trickey*, Sara Croxford, Eva Emanuel, Samreen Ijaz, Matthew Hickman, Joanna Kesten, Clare Thomas, Claire Edmundson, Monica Desai, Peter Vickerman

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Syringes with attached needles (termed fixed low dead space syringes [LDSS]) retain less blood following injection than syringes with detachable needles, but evidence on them reducing blood-borne virus transmission among people who inject drugs (PWID) is lacking. Utilizing the UK Unlinked Anonymous Monitoring cross-sectional bio-behavioral surveys among PWID for 2016/18/19 (n=1429), we showed that always using fixed LDSS was associated with 76% lower likelihood (adjusted odds ratio =0.24, 95% confidence interval [CI]:. 08-.67) of recent hepatitis C virus infection (RNA-positive and antibody-negative) among antibody-negative PWID compared to using any syringes with detachable needles.

Original languageEnglish
Pages (from-to)1073-1077
Number of pages5
JournalClinical Infectious Diseases
Volume75
Issue number6
DOIs
Publication statusPublished - 15 Sept 2022

Bibliographical note

Publisher Copyright:
© 2022 The Author(s). Published by Oxford University Press for the Infectious Diseases Society of America.

Keywords

  • HCV
  • IDU
  • high dead space syringes
  • injecting drugs
  • low dead space syringes

Fingerprint

Dive into the research topics of 'The Effectiveness of Low Dead Space Syringes for Reducing the Risk of Hepatitis C Virus Acquisition among People Who Inject Drugs: Findings from a National Survey in England, Wales, and Northern Ireland'. Together they form a unique fingerprint.

Cite this